PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 10, 2003Proceedings of the National Academy of Sciences265 citationsOpen Access

Function and glycosylation of plant-derived antiviral monoclonal antibody

View Full Paper
KKKisung KoYTYoram TekoahPRPauline M. Rudd

Key Points

Key points are not available for this paper at this time.

Abstract

Plant genetic engineering led to the production of plant-derived mAb (mAbP), which provides a safe and economically feasible alternative to the current methods of antibody production in animal systems. In this study, the heavy and light chains of human anti-rabies mAb were expressed and assembled in planta under the control of two strong constitutive promoters. An alfalfa mosaic virus untranslated leader sequence and Lys-Asp-Glu-Leu (KDEL) endoplasmic reticulum retention signal were linked at the N and C terminus of the heavy chain, respectively. mAbP was as effective at neutralizing the activity of the rabies virus as the mammalian-derived antibody (mAbM) or human rabies Ig (HRIG). The mAbP contained mainly oligomannose type N-glycans (90%) and had no potentially antigenic alpha(1,3)-linked fucose residues. mAbP had a shorter half-life than mAbM. The mAbP was as efficient as HRIG for post-exposure prophylaxis against rabies virus in hamsters, indicating that differences in N-glycosylation do not affect the efficacy of the antibody in this model.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ko et al. (2003) studied this question.

synapsesocial.com/papers/6a6b3edd285b5e3c3db3a8b5https://doi.org/10.1073/pnas.0832472100
Ask AI
Helpful
Bookmark
Share
View Full Paper